Avail Clinical Research Announces Irritable Bowel Syndrome Research Studies in DeLand, FL
Irritable Bowel Syndrome research studies for those already diagnosed with IBS being conducted in DeLand, FL.
DeLand, FL, January 27, 2010 --(PR.com)-- Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, FL, announces the launch of several research studies to test investigational treatment options for those already diagnosed with Irritable Bowel Syndrome (IBS). “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from Irritable Bowel Syndrome,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for Irritable Bowel Syndrome." Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.
The research studies will enroll those already diagnosed with IBS, which includes symptoms like abdominal pain, bloating, diarrhea and constipation. In order to participate in the studies volunteers must be diagnosed with IBS. Avail Clinical Research will not take volunteers who:
have any evidence or treatment of malignancy within the previous 5 years,
have a history of alcohol or substance abuse within the previous 5 years,
have used an investigatory drug or participated in an investigatory study within 30 days of the screening,
are pregnant, or
are breast-feeding.
Irritable bowel syndrome (IBS) refers to a complex disorder of the lower intestinal tract. It is mainly characterized by a pattern of symptoms that is often worsened by emotional stress. Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Avail Clinical Research at (386) 310-1334, or at www.AvailClinical.com.
###
The research studies will enroll those already diagnosed with IBS, which includes symptoms like abdominal pain, bloating, diarrhea and constipation. In order to participate in the studies volunteers must be diagnosed with IBS. Avail Clinical Research will not take volunteers who:
have any evidence or treatment of malignancy within the previous 5 years,
have a history of alcohol or substance abuse within the previous 5 years,
have used an investigatory drug or participated in an investigatory study within 30 days of the screening,
are pregnant, or
are breast-feeding.
Irritable bowel syndrome (IBS) refers to a complex disorder of the lower intestinal tract. It is mainly characterized by a pattern of symptoms that is often worsened by emotional stress. Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Avail Clinical Research at (386) 310-1334, or at www.AvailClinical.com.
###
Contact
Avail Clinical Research
Sach Chitnis
(386) 310-1334
availclinical.com
Contact
Sach Chitnis
(386) 310-1334
availclinical.com
Categories